Hosted on MSN1d
FDA grants clearance to icotec’s BlackArmor implants to treat spinal infection
The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).
Medscape11h
Fibromyalgia Pain Might Start in the Spinal Cord, Study Suggests
Researchers found spinal disinhibition in people with fibromyalgia, adding new clues about the role of central pain ...
NervGen In Spotlight As It Approaches Clinical Proof Of Concept Readout For Spinal Cord Regeneration
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
KUOW7d
'A hearing aid for the spinal cord.' New device helps people with paralysis regain motor function
The ARC-EX stimulator, recently approved by the FDA, makes it easier for the spinal cord to hear what the brain wants to do ...
WebMD13d
Getting a Laminectomy: Before, During, and After
Laminectomy is a type of spinal decompression surgery where a ... such as physical therapy and prescription medications. If they don't help, then they could suggest a laminectomy.
MP asks government to authorise local manufacture of drug for rare disease to slash cost
A Rajya Sabha MP urges the health minister to enable local production of Risdiplam, a vital drug for spinal muscular atrophy, ...
The Business Journals28d
Spinal Simplicity sees revenue skyrocket 616% with new devices in the pipeline
from slowly building its team to raising millions to gaining Food and Drug Administration approvals. Much of Spinal Simplicity’s recent success has hinged on its having “the right product at ...
STAT28d
FDA OKs novel device for non-invasive treatment of spinal cord injuries
Spinal cord injuries dramatically reduce a person’s mobility and independence, but a new device could aid rehabilitation efforts. Onward Medical received Food and Drug Administration clearance ...
Pharmaceutical Technology11d
IMC-2017 by ImmuneCyte for Spinal Cord Disorders: Likelihood of Approval
IMC-2017 is under clinical development by ImmuneCyte and currently in Phase I for Spinal Cord Disorders. According to GlobalData, Phase I drugs for Spinal Cord Disorders have an 86% phase transition ...
Medscape3d
Complications Associated With the Use of Rogozinski and Simmons Spinal Instrumentation Systems: One Center's Experience
Food and Drug Administration-approved, Investigational Device Exemption studies. The purpose of both studies was to evaluate the safety and efficacy of the Rogozinski Spinal Instrumentation System ...